KIM-1 and NGAL: new markers of obstructive nephropathy - Wikidata - awgldk - TriplyDB

KIM-1 and NGAL: new markers of obstructive nephropathy

KIM-1 and NGAL: new markers of obstructive nephropathy

http://www.wikidata.org/entity/Q34594776

about

Emerging urinary markers of renal injury in obstructive nephropathy Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology Congenital urinary tract obstruction: the long view.Prognostic factors and biomarkers of congenital obstructive nephropathy.Paediatric normative data for urine NGAL/creatinine ratio.Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty Urinary biomarker detection of melamine- and cyanuric acid-induced kidney injury in rats.Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study.Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes Molecular basis of renal adaptation in a murine model of congenital obstructive nephropathy.Urine neutrophil gelatinase-associated lipocalin identifies unilateral and bilateral urinary tract obstruction Urinary neutrophil gelatinase-associated lipocalin (NGAL) might be an independent marker for anticipating scar formation in children with acute pyelonephritis.Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome: Preliminary Report.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children Urine NGAL and KIM-1 in children and adolescents with hyperuricemia Establishment of Simple and Routine Methods in Early Diagnosis of Gentamicin-Induced Kidney Injury Based on a Rat Model.Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction.Serum and urinary NGAL in septic newborns.Urinary kidney injury molecule‑1 as an early diagnostic biomarker of obstructive acute kidney injury and development of a rapid detection method.Biomarkers of acute kidney injury in neonatal encephalopathy.Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review.Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.Do serum and urinary concentrations of kidney injury molecule-1 in healthy newborns depend on birth weight, gestational age or gender?Plasma levels of neutrophil gelatinase-associated lipocalin in children with heart failure.Urinary biomarkers for renal tract malformations.The molecular biology of pelvi-ureteric junction obstruction.Does maternal hydronephrosis have an impact on urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels?Analysis of urine biomarkers for early determination of acute kidney injury in non-septic and non-asphyxiated critically ill preterm neonates.Urinary biomarkers of chronic allograft nephropathy.Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study.Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels.Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.Tubular urinary biomarkers do not identify aetiology of acute kidney injury in kidney transplant recipients.Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults.Urinary kidney injury molecules in children with febrile seizures.Factors limiting usefulness of serum and urinary NGAL as a marker of acute kidney injury in preterm newborns.Urine Neutrophil Gelatinase Associated Lipocalin to Creatinine Ratio: A Novel Index for Steroid Response in Idiopathic Nephrotic Syndrome.

P2860

Q26827757-E15B32A2-9C3C-453D-8099-2A0B9FB25E00 Q26829452-DF39AFD8-FF1C-4849-B56B-C88976B15706 Q27009005-056308A0-4C42-4FA7-936D-6B988F58BFCE Q30277907-2F5E5506-66DE-419C-9E9F-C3169F8C0456 Q30590366-F8595F77-3264-4D34-9A6B-3902F93CBF52 Q33930517-182A43DC-8092-40A0-AE34-EF6382D956E2 Q34275526-90356716-7A39-44E6-A14E-30B5C5BE3AD9 Q34399423-6F1B5E06-94C0-4D11-8F56-6E8227C83A7E Q34525437-1294D772-20AE-4E1A-8E63-81A357809FF7 Q34984028-B829857D-37C2-425D-AED4-26182F33CD5E Q35661946-F70CFBE4-FEFF-4BB2-9EC4-2172C8E1C6A1 Q35694875-76027CF1-44A2-4F05-9AD9-F9F3BDEB943F Q36207035-56E488DA-28AF-4864-B06E-85D4FC169B82 Q36322918-75115036-1103-445C-B251-78C7D0106BD5 Q37043276-0E4912FC-6E13-4521-B334-EAA54F345586 Q37222843-68DCC3F1-C82E-413C-9405-43D6C85830B0 Q37484299-0556D178-442B-4BD5-9BBF-76E527B21A39 Q37570931-D3EADC0D-BBD1-4D82-B4BF-052E4A001A3F Q37722168-E522B5D3-5E0E-4D4D-B932-2F4A16519CBA Q38058688-CCC6E740-3473-47D7-858A-7F12603C2999 Q38235880-9343EAB8-B2FF-45B8-9FBA-738791C3BDE4 Q38813024-628632F7-DB39-4D62-A772-CAB5B19C8CB2 Q38816521-10746E88-7487-42DE-9E4C-B6B3FCC892C8 Q38936504-0B55A61A-9541-4157-AF28-F38DB02C5618 Q38993548-A0C3609B-9745-4520-8840-6770BC3E0DBF Q39175631-5072FA60-195C-42C7-BFD1-33D9E9D6F0BD Q39813106-6A36E75C-2D0B-400F-AADA-65F11DBA3C91 Q40830582-3F82EA47-588F-4650-B57F-A9B017957F80 Q40964596-5F5C6DA1-CA7D-411D-8685-1613C9FB1171 Q41436493-6909567B-2405-4FE9-895A-F69ED384CE1B Q41507918-00DC84EC-3392-4416-BD17-28DC156EA796 Q41590362-FD299302-D63C-45DB-A4C2-6FB5039FCEA5 Q42218148-4E8D1127-5846-487B-9F67-CC738ACD8252 Q42229227-0662D8C7-4596-4C9C-95C0-60DE564C9D55 Q42259357-A84B8E2D-A26F-4A4E-B924-6BA440368E6E Q42546522-D2EE6E7C-7B50-4C1E-9836-968DB013192F Q48334562-9D63A3D7-0F4B-4213-9792-D56ECFDB6684 Q51552421-C897BC7E-E563-4770-AC2D-473CADAFCEA1 Q53635288-E18136DA-C0B9-43CC-BA49-9D612F4E995B Q53836853-CAFD0D08-FDB7-4FDB-86D0-A29EA1865BF4

P2860

KIM-1 and NGAL: new markers of obstructive nephropathy

http://www.wikidata.org/entity/Q34594776

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

KIM-1 and NGAL: new markers of obstructive nephropathy

@ast

KIM-1 and NGAL: new markers of obstructive nephropathy

@en

KIM-1 and NGAL: new markers of obstructive nephropathy

@nl

type

label

KIM-1 and NGAL: new markers of obstructive nephropathy

@ast

KIM-1 and NGAL: new markers of obstructive nephropathy

@en

KIM-1 and NGAL: new markers of obstructive nephropathy

@nl

prefLabel

KIM-1 and NGAL: new markers of obstructive nephropathy

@ast

KIM-1 and NGAL: new markers of obstructive nephropathy

@en

KIM-1 and NGAL: new markers of obstructive nephropathy

@nl

P1433

Q34594776-DBF4C427-8499-41A3-8406-63D78DC5517D

P1476

Q34594776-8BA5C331-ED73-4C01-86F6-BDA440F106C9

P2093

Q34594776-64953E3A-EA14-4100-B551-BFC06662E178

Q34594776-A36F4D48-4351-47FD-AACD-1E282480B9A5

P2860

Q34594776-0F098731-EBD8-49FE-B825-8CF78F010B14

Q34594776-2788EAB8-E48A-4133-8FEF-F602481886DC

Q34594776-3728F631-376B-4FD7-AEA2-A77587644BC1

Q34594776-389F101C-7B22-420A-A58D-DEA57854FCAD

Q34594776-3B7B4B11-5876-4B09-B457-8330C460245C

Q34594776-40C13A24-EAA7-4D26-9BE5-96F36A25E4C2

Q34594776-4571693A-D07E-48D2-8B9A-4F8E7BB8C0B7

Q34594776-50C87A49-DDAB-4AD2-97BA-5F4A2B10E2E2

Q34594776-5E90A96A-7926-4487-8112-40B1B5E9CA4C

Q34594776-80563287-9183-4093-B6BC-F440E648ABE2

P2888

Q34594776-FFE31B82-7E2D-4D00-B374-58CD18831F8B

P304

Q34594776-FCB25842-9DF6-4350-B007-DEF0C160B8A0

P31

Q34594776-14D0519F-2460-4C04-B156-1F8BBAEAD0A6

P356

Q34594776-C15931D5-AD49-4EBE-BA11-CB6FE4A198DF

P433

Q34594776-EC2EEDA0-984A-4769-95FD-FB320BC605FC

P478

Q34594776-738B6161-135F-4438-BA70-888D80741B60

P50

Q34594776-3C1A340C-6613-4AEA-B7CB-A36A316D4513

Q34594776-65FE2608-318E-4900-822C-AC2A6E407242

Q34594776-D3102D7E-8B45-446D-90B8-A6ADFE333E20

P577

Q34594776-F8078090-18B7-4E45-97EA-F1A9366EBDC6

P5875

Q34594776-86045A56-EF88-439D-96E7-884439ADDC5B

P6179

Q34594776-A93D2BCE-B72D-4054-BD87-4F0DC9398884

P698

Q34594776-FC3649A6-F898-4571-A922-B5288D8AAAFD

P932

Q34594776-1CCA2355-702B-4D8E-91FB-5C4D3C9D7C94

P356

S00467-011-1773-5

P1433

Pediatric Nephrology

P1476

KIM-1 and NGAL: new markers of obstructive nephropathy

@en

P2093

Anna Wasilewska

http://www.w3.org/2001/XMLSchema#string

Walentyna Zoch-Zwierz

http://www.w3.org/2001/XMLSchema#string

P2860

The lipocalin protein family: structure and function

Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction.

Obstructive nephropathy: towards biomarker discovery and gene therapy.

Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy.

Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury.

Dual action of neutrophil gelatinase-associated lipocalin.

Emerging urinary biomarkers in the diagnosis of acute kidney injury

Assay validation for KIM-1: human urinary renal dysfunction biomarker.

Biomarkers in acute and chronic kidney disease.

Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.

P2888

s00467-011-1773-5

P304

579-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-011-1773-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Wojciech Dębek

Elżbieta Kuroczycka-Saniutycz

Katarzyna Taranta-Janusz

P577

2011-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49797069

http://www.w3.org/2001/XMLSchema#string

P6179

1018027317

http://www.w3.org/2001/XMLSchema#string

P698

21279810

http://www.w3.org/2001/XMLSchema#string

P932

3043232

http://www.w3.org/2001/XMLSchema#string